Home > Products > IL13 & IL4
> Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (scIgG)
Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (scIgG) (CAT#: SCIGG-173)
Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-IL13 and anti-IL4 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy.
There are currently no customer reviews or questions for Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (scIgG) (SCIGG-173). Click the button below to contact us or submit your feedback about this product.